Cetirizini dihydrochloridum, Pseudoephedrini hydrochloridum

Medicinal product name Cirrus 5 mg/120 mg prolonged release tablets
Pharmaceutical form Prolonged-release tablet
Strength 5 mg/120 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
04-0345-01N14 Is available
Legal status Rx Prescription (Pr.III)
Package leafletMS Word document 03-06-2021
Summary of product characteristicsMS Word document 03-06-2021
ATC code R01BA52 Nasal preparations

Important notice

Additional information regarding the use for persons aged 75+

If used as "NASAL PREPARATIONS"
SubstanceClassComment
Cetirizini dihydrochloridumCSuitable for older persons, with specific cautions. Reduce the dose and/or increase the dosing interval in even moderate renal insufficiency. May cause fatigue.
Pseudoephedrini hydrochloridumCSuitable for older persons, with specific cautions. For short-term use only (<10 days) as necessary. Increase the dosing interval in even mild renal insufficiency. Take into account sympathomimetic effects.

Medicinal products (2)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(113464 containers)
Tamro, Olainfarm, Recipe Plus, Magnum Medical, Baltfarm "Vita-Farm", Euroaptieka, Oribalt Rīga, Jelgavfarm N14
(5 mg/120 mg)
PVC/Al blister 7.09  04-0345-01 Labelling text Labelling text Dec 10, 2020
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N28
(5 mg/120 mg)
PVC/Al blister    04-0345-02 Labelling text Labelling text Dec 10, 2020

Registration information

Marketing authorisation No. 04-0345
Date of authorisation Jul 5, 2004
MA valid until For unlimited time
Marketing authorisation holder, country UCB Pharma Oy Finland, Finland